Comparing two methods for treating blocked stomach openings
Official title: A Randomized Trial Comparing Endoscopic UltraSound-guided GasTrojejunostomy (EUS-GJ) and Surgical GastrojejunOstomy (S-GJ) for the Management of Malignant gastRic outlEt Obstruction
Run by AdventHealth · NCT06128018 · Data updated 2026-11-12
This study is testing which of two procedures, one done with an endoscope and the other through surgery, is safer and works better for people with blocked stomach openings caused by cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | AdventHealth Academic / other |
| Locations | 1 site (Orlando, Florida) |
| Status | Recruiting |
| Started | November 1, 2023 |
| Main results expected | September 8, 2026 |
| Study ends | March 8, 2027 |
| Registry record updated | September 4, 2026 |
| Trial ID | NCT06128018 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with evidence of an obstructing neoplasm in the distal stomach or duodenum.
✕Probably not a fit
Patients with a poor prognosis or those who are candidates for potential surgical resection of their cancer may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study aims to compare the outcomes of two procedures for managing malignant gastric outlet obstruction: Endoscopic Ultrasound-guided gastrojejunostomy (EUS-GJ) and Surgical gastrojejunostomy (S-GJ). Participants will be randomly assigned to one of the two procedures and will be monitored for up to 12 months to assess the rates of procedure-related adverse events. The study seeks to determine which method is safer and more effective for patients with this condition.
Why it matters
Potential benefit: If successful, this study could provide insights into the safer and more effective management of malignant gastric outlet obstruction.
How similar studies have gone: While similar studies have explored gastrojejunostomy techniques, this specific comparison of EUS-GJ and S-GJ is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ≥ 18 years of age. 2. Radiographic OR Endoscopic evidence of an obstructing neoplasm in the distal stomach or duodenum. 3. GOOSS of 0 or 1 4. BOTH surgical and endoscopic GJ are technically and clinically feasible 5. Can understand and is willing to sign informed consent form prior to the initiation of any study procedures (or when applicable the subject's LAR). Exclusion Criteria: 1. \< 18 years of age 2. ECOG \>2 3. Expected survival (determined by the treating oncologist) is less than 2 months. 4. Candidates for potential resection of the cancer and obstructed anatomical area (this includes patients with borderline resectable pancreatic cancer) 5. Peritoneal carcinomatosis with associated bowel obstruction on imaging or during laparoscopy 6. Large volume ascites (patients with moderate volume ascites may undergo IR guided drainage prior to randomization) 7. Anatomical factors that technically hinder EUS-GJ OR Surgical-GJ (diffuse tumor involvement in path of LAMS or surgery, surgically altered anatomy that interferes with the ability to perform an anastomosis etc) 8. Pregnancy
Where it's running
-
AdventHealth Orlando
Orlando, Florida, United States Recruiting
Study contacts
- Principal investigator: Kambiz Kadkhodayan, MD — AdventHealth
- Study coordinator: Bridget Miller, MPH, MS
- Email: bridget.miller@adventhealth.com
- Phone: (407)303-9736
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
EUS-directed transenteric ERCP to reach an inaccessible papilla or biliodigestive anastomosis
This will try EUS-directed transenteric ERCP to reach and treat blocked bile ducts in adults whose papilla or biliodigestive anastomosis cannot be reached by conventional endoscopy or enteroscopy.
-
Hepatic artery infusion therapy for liver metastases after pancreatic/duodenal cancer surgery
This study tests whether delivering chemotherapy directly to the liver via a pump can help people with pancreatic or duodenal cancer that has spread mainly to the liver after surgery and prior chemotherapy.
-
Donor Breast Milk with Early Iron Supplementation in Very Preterm Infants
In very preterm babies who mainly receive donor breast milk, this study tests whether starting iron supplementation earlier (around when feeding reaches 80 ml/kg/day) can raise ferritin and hematocrit levels by days 14 and 28.
-
Diet to reduce pain from diabetic peripheral neuropathy
This compares a whole-food, plant-based, no-added-oil diet with usual medications to see if it lowers pain and improves nerve symptoms in adults with painful diabetic neuropathy.
-
One preoperative dose of IV methadone for pain after knee replacement
This study tests whether a single IV methadone dose given before total knee replacement can improve postoperative pain control and reduce later pain medicine use for patients undergoing the surgery.
-
Professional Readiness Through Emotional Preparedness (PREP) for Nurse Residents
The PREP program tests a 5-month educational series to see if it improves emotional well-being and work readiness for nurse residents.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.